Randomised phase II trial of irinotecan with hyaluronic acid (HyCAMPTM) versus irinotecan as treatment for patients with metastatic colorectal cancer who have failed 5-FU [5-fluorouracil] based chemotherapy

Trial Profile

Randomised phase II trial of irinotecan with hyaluronic acid (HyCAMPTM) versus irinotecan as treatment for patients with metastatic colorectal cancer who have failed 5-FU [5-fluorouracil] based chemotherapy

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Irinotecan hyaluronic acid complex (Primary) ; Irinotecan
  • Indications Colorectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 May 2009 New source identified and integrated (Australian New Zealand Clinical Trials Registry)
    • 29 May 2007 Status changed from 'in progress' to 'completed'
    • 11 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top